Australia markets closed

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
7.71-0.18 (-2.28%)
At close: 04:00PM EDT
7.74 +0.03 (+0.39%)
Pre-market: 06:06AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
15,558,000
15,879,000
16,658,000
16,887,000
18,854,000
Cost of revenue
8,101,000
8,284,000
8,933,000
9,351,000
10,558,000
Gross profit
7,456,000
7,594,000
7,726,000
7,537,000
8,296,000
Operating expenses
Research development
938,000
967,000
997,000
1,010,000
1,213,000
Selling general and administrative
3,533,000
3,528,000
3,671,000
3,806,000
4,214,000
Total operating expenses
4,471,000
4,495,000
4,668,000
4,816,000
5,427,000
Operating income or loss
2,985,000
3,099,000
3,058,000
2,721,000
2,869,000
Interest expense
859,000
891,000
963,000
881,000
920,000
Total other income/expenses net
-2,514,000
-1,480,000
-6,500,000
-3,108,000
-4,480,000
Income before tax
-457,000
658,000
-4,406,000
-1,265,000
-2,596,000
Income tax expense
151,000
211,000
-168,000
-278,000
-195,000
Income from continuing operations
-581,000
456,000
-4,100,000
-1,000,000
-2,472,000
Net income
-615,000
417,000
-3,990,000
-999,000
-2,150,000
Net income available to common shareholders
-615,000
417,000
-3,990,000
-999,000
-2,399,000
Basic EPS
-
0.38
-3.64
-0.91
-2.35
Diluted EPS
-
0.38
-3.64
-0.91
-2.35
Basic average shares
-
1,102,000
1,095,000
1,091,000
1,021,000
Diluted average shares
-
1,107,000
1,095,000
1,091,000
1,021,000
EBITDA
-
2,879,000
-1,886,000
1,338,000
166,000